with the above schedule will give an aciclovir concentration not greater than 0.5% w/v.
Since no antimicrobial preservative is included, reconstitution and dilution must be carried out under full aseptic conditions, immediately before use, and any unused solution discarded.
Should any visible turbidity or crystallisation appear in the solution before or during infusion, the preparation should be discarded.
7. Marketing authorisation holder
Wockhardt UK Limited
Ash Road North
Wrexham LL13 9UF
United Kingdom
8. Marketing authorisation number(s)
PL 29831/0320
9. Date of first authorisation/renewal of the authorisation
Date of first authorisation: 6 May 2008
10. Date of revision of the text
04 June 2015
